Dr. Bill Louv was named Chief Executive Officer of the CEO Roundtable on Cancer and Project Data Sphere in March 2022 after serving as Interim CEO since January 1, 2022. He joined Project Data Sphere in March 2018 as President. Previously, he held key leadership positions in the pharmaceutical industry for nearly 30 years. He joined the pharmaceutical industry in 1986 as head of biostatistics at Merrell Dow and advanced to the position of VP of biostatistics, epidemiology and clinical data management at GlaxoWellcome in 1998. Dr. Louv made a significant career change in 1999 when he became VP of IT for GlaxoSmithKline';s R&D organization. He was named Chief Information Officer for GSK in 2007. In 2011, Dr. Louv was promoted to Senior VP of Core Business Services, which included IT, procurement, accounting, and real estate. He was a member of GSK's Corporate Executive Management team from 2007 until his retirement in May 2016.
Dr. Louv has consulted with many organizations on health care analytics and opportunities to leverage big data. He is a Non-Executive Director of River Logic Inc., a leader in prescriptive analytics and integrated business planning, and he is Deputy Chairman of ClinPal, a cloud-based clinical trial platform. In his early career, Dr. Louv was a member of the technical staff at Bell Laboratories where he developed forecasting algorithms for signaling networks. Subsequently he was Associate Professor of Biostatistics at the University of Alabama at Birmingham. While at these research organizations, he published more than 25 academic papers.